| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $33.4M | +27.1% |
| SG&A Expense | $17.3M | -28.8% |
| Operating Income | -$50.7M | -0.2% |
| Interest Expense | $3.7M | +541.9% |
| Income Tax | $0 | — |
| Net Income | -$51.1M | -3.8% |
| EPS (Basic) | -$1.32 | -1.5% |
| EPS (Diluted) | -$1.32 | -1.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.3M | -66.5% |
| Short-term Investments | $41.4M | -23.8% |
| Current Assets | $55.0M | -41.4% |
| Total Assets | $56.7M | -40.9% |
| Current Liabilities | $38.4M | +283.3% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $38.4M | +10.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.9M | -12.5% |
| Capital Expenditures | $138K | +206.7% |
| Investing Cash Flow | $15.0M | +127.8% |
| Financing Cash Flow | $438K | -98.1% |
| Free Cash Flow | -$40.0M | -12.8% |
| Stockholders' Equity |
| $18.3M |
| -70.0% |